Abstract
Background
The prognostic factors which can improve the overall survival (OS) of patients with T4 gastric carcinoma (GC) are still controversial: a meta-analysis was conducted to analyze the impact of clinicopathological parameters on survival after MOR among patients with T4 GC.
Methods
A systematic search was performed. Odd risks (ORs) of patients with T4 GC were used to calculate the relationship between clinicopathological parameters and OS.
Results
Nine studies involving 941 patients with T4 GC were identified. Well-moderate differentiation led to increased 1-, 3-, 5-year OS with an OR of 2.63, 1.58 and 1.45. Borrmann type I–II led to increased 1-, 3-year OS with an OR of 1.67 and 2.08. No lymph node metastasis led to increased 1-, 3-, 5-year OS with an OR of 7.16, 3.18 and 3.71. Total gastrectomy led to increased 1-, 3-year OS with an OR of 2.01 and 1.79. ≥2 Organs resected led to increased 1-, 3-year OS with an OR of 2.19 and 2.19. TNM stage II–III led to increased 1-, 3-year OS with an OR of 3.68 and 5.75. Curative resection led to increased 1-, 3-, 5-year OS with an OR of 4.46, 5.80 and 5.98.
Conclusion
Well-moderate differentiation, Borrmann type I–II, no lymph node metastasis, total gastrectomy, ≥2 organs resected, TNM stage II–III and curative resection were positive prognostic factors for OS of patients with T4 GC.
Similar content being viewed by others
References
Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50(7):1330–44.
Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol/Hematol. 2005;54(3):209–41.
Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, et al. Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg. 2015;262(6):991–8.
Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol. 2009;100(2):115–20.
Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Surgical outcomes in patients with T4 gastric carcinoma. J Am Coll Surg. 2006;202(2):223–30.
Kim DY, Joo JK, Seo KW, Park YK, Ryu SY, Kim HR, et al. T4 gastric carcinoma: the benefit of non-curative resection. ANZ J Surg. 2006;76(6):453–7.
Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, et al. Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol. 2010;101(7):622–5.
Zu G, Ji A, Zhou T, Che N. Clinicopathological significance of SIRT1 expression in colorectal cancer: a systematic review and meta-analysis. Int J Surg. 2016;26(2):32–7.
Carboni F, Lepiane P, Santoro R, Lorusso R, Mancini P, Sperduti I, et al. Extended multiorgan resection for T4 gastric carcinoma: 25-year experience. J Surg Oncol. 2005;90(2):95–100.
Oñate-Ocaña LF, Becker M, Carrillo JF, Aiello-Crocifoglio V, Gallardo-Rincón D, Brom-Valladares R, et al. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol. 2008;98(5):336–42.
Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198(1):25–30.
Cheng CT, Tsai CY, Hsu JT, Vinayak R, Liu KH, Yeh CN, et al. Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol. 2011;18(6):1606–14.
Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg. 2012;203(1):107–11.
Xiao L, Li M, Xu F, Ye H, Wu W, Long S, et al. Extended multi-organ resection for cT4 gastric carcinoma: a retrospective analysis. Pak J Med Sci. 2013;29(2):581–5.
Shan G, Rong Y, Jiang D, Zhu D, Zhang L, Jiang J. Prognostic analysis for patients with T4 gastric cancer undergoing radical resection. Chin J Gen Surg. 2013;22(10):1271–5.
Yiming L, Latengbaolide A, Bo C, Caigang L, Huimian X. Comparison of surgical methods and prognostic factors in T4 gastric cancer. Chin Ger J Clin Oncol. 2010;9(7):391–5.
Lin D, Ping L, Liu C, Wang H, Altbad W, Zhao C, et al. Surgical outcomes in patients with T4 gastric carcinoma: a retrospective study of 162 patients. Chin Ger J Clin Oncol. 2009;8(10):599–602.
McCulloch P. The role of surgery in patients with advanced gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20(4):767–87.
McCullough JA, Evoy D, Sweeney KJ, Meyers C, Ravi N, Keeling N, et al. D2 lymphadenectomy in the management of gastric cancer. Ir J Med Sci. 2003;172(3):132–5.
Radovanović D, Stevanović D, Pavlović I, Bajec A, Vekić B, Mitrović N. Multiorgan resection in patients with gastric cancer. Med Pregl. 2004;57(9–10):480–6.
Kim ER, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2015;102(11):1394–401.
Isozaki H, Tanaka N, Tanigawa N, Okajima K. Prognostic factors in patients with advanced gastric cancer with macroscopic invasion to adjacent organs treated with radical surgery. Gastric Cancer. 2000;3(4):202–10.
Kobayashi A, Nakagohri T, Konishi M, Inoue K, Takahashi S, Itou M, et al. Aggressive surgical treatment for T4 gastric cancer. J Gastrointestinal Surg. 2004;8(4):464–70.
Kim JH, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, et al. Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg. 2009;32(4):198–204.
Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M, et al. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol. 2016;42(1):132–9.
Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX, et al. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol. 2014;20(25):8244–52.
Acknowledgements
G. Zu and X. Zhang designed the research; W. Li and T. Zhang conducted the research; W. Li and Y. Sun analyzed data; G. Zu wrote the draft; all authors read, reviewed and approved the final manuscript. G. Zu and X. Zhang had primary responsibility for final content.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Zu, G., Zhang, T., Li, W. et al. Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis. Clin Transl Oncol 19, 750–760 (2017). https://doi.org/10.1007/s12094-016-1600-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-016-1600-3